Pyridin‐4‐ol–hydro­quinone (1/1)

By  

Acta Crystallographica Section E, Vol. 63, Iss. 1, 2007-01 ,pp. : o193-o194

John Wiley & Sons Inc

Access to resources Recommend Favorite

(4R,9S)‐4‐Hydro­xy­methyl‐3,8‐dioxa‐1,6‐di­aza­spiro­[4.4]­nonane‐2,7‐di­thione monohydrate

By  

Acta Crystallographica Section E, Vol. 60, Iss. 12, 2004-12 ,pp. : o2399-o2401

John Wiley & Sons Inc

Access to resources Recommend Favorite

(8S)‐3‐(2‐De­oxy‐3,5‐di‐O‐p‐toluoyl‐α‐d‐erythro‐pentofuranos­yl)‐3,6,7,8‐tetra­hydro­imidazo[4,5‐d][1,3]diazepin‐8‐ol

By  

Acta Crystallographica Section E, Vol. 62, Iss. 10, 2006-10 ,pp. : o4216-o4218

John Wiley & Sons Inc

Access to resources Recommend Favorite

9‐(Phenylsulfonyl)‐9H‐carbazol‐2‐ol

By  

Acta Crystallographica Section E, Vol. 63, Iss. 5, 2007-05 ,pp. : o2472-o2473

John Wiley & Sons Inc

Access to resources Recommend Favorite

(2Z)‐2‐(Anthracen‐9‐yl­methyl­ene)‐5,6‐di­hydro­imidazo­[2,1‐b]­thia­zol‐3(2H)‐one

By  

Acta Crystallographica Section E, Vol. 61, Iss. 2, 2005-02 ,pp. : o220-o221

John Wiley & Sons Inc

Access to resources Recommend Favorite